Vivasure Medical , Ltd.: PMA approval for PerQseal® Elite Vascular Closure Device

Vivasure Medical , Ltd. (Galway): PMA approval for PerQseal® Elite Vascular Closure Device. Dated 19 days ago, it is in the active follow-up window. Score 85/100. As of 2026-11-04, from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration).

Data as of · Compiled by Zalwin from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)

Free preview: all 8 published fields of this record are shown below. Locked: 499 related FdaApprovalPulse records and the 4-column CSV export.

FieldValue
SponsorVivasure Medical , Ltd.
ProductPerQseal® Elite Vascular Closure Device
Generic / ingredientDevice, hemostasis, vascular
ApprovalPMA original approval (new class III device)
ApplicationP250015
Decided2026-10-16
Panel / classCardiovascular
Sponsor locationGalway
Peer records CSV (500 records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch Vivasure Medical , Ltd.

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Unlock Vivasure Medical + 500 peer records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Product · Approval · Decided · official source URL

  • Source agency: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)
  • Record date: 2026-10-16
  • Data refreshed: 2026-11-04
  • Refunds on request within 14 days

Search all records free →

Top FdaApprovalPulse records: Instylla, Inc. · Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) · Cerenovus, Inc. · Advanced Medical Solutions Limited · Lenstec, Inc. · Browse all by state and category →

LIVE PUBLIC DATA Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration) · Last refreshed: Wed, 04 Nov 2026 06:06:18 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Search, filter and export more FdaApprovalPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

85 / 100 Score

  • Decided in the last 30 days.
  • A new product launch.

What is the FdaApprovalPulse record for Vivasure Medical , Ltd. in Galway?

The FDA approved PerQseal® Elite Vascular Closure Device (P250015) for Vivasure Medical , Ltd. on 2026-10-16: PMA original approval (new class iii device).

How does Vivasure Medical , Ltd. compare to other FdaApprovalPulse records?

It is 19 days old, still within a typical 45-day follow-up window. Its Score of 85/100 puts it among the stronger signals in this feed.

Vivasure Medical , Ltd. vs. top 3 peers

OrganizationLocationRecord date
Vivasure Medical , Ltd.Galway2026-10-16
Edwards Lifesciences, LLCIrvine, CA2026-10-01
Rejoni, Inc.Bedford, MA2026-09-28
Bard Peripheral Vascular, Inc.Tempe, AZ2026-09-25

Related records

FdaApprovalPulse: PMA original approval (new class III device)

How to monitor Vivasure Medical , Ltd. and peer pma original approval (new class iii device) records

Get new FdaApprovalPulse records like Vivasure Medical , Ltd. by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get new approvals in your categories

FdaApprovalPulse emails new device and drug approvals matching your approval types.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

From openFDA (PMA and Drugs@FDA). openFDA can lag FDA decisions by days to weeks. Drug supplement types follow the FDA submission class (labeling and REMS, manufacturing/CMC, efficacy, other). Company and product level only. Verify on FDA databases before relying on an approval.

Often used together